Keiser J, Utzinger J, 2005. Emerging foodborne trematodiasis. Emerg Infect Dis 11: 1507ā1514.
Marcos LA, Terashima A, Gotuzzo E, 2008. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis 21: 523ā530.
Cabada MM, White AC Jr, 2012. New developments in epidemiology, diagnosis, and treatment of fascioliasis. Curr Opin Infect Dis 25: 518ā522.
Welch RD, Smith PH, Malone JB, Holmes RA, Geaghan JP, 1987. Herd evaluation of Fasciola hepatica infection levels in Louisiana cattle by an enzyme-linked immunosorbent assay. Am J Vet Res 48: 345ā347.
Knapp SE, Dunkel AM, Han K, Zimmerman LA, 1992. Epizootiology of fascioliasis in Montana. Vet Parasitol 42: 241ā246.
Kane YI, 2010. A Walk on the Wild Sideāfor Lunch. Wall Street Journal. New York: Dow Jones and Company, Inc. Available at: http://online.wsj.com/article/SB10001424052748704631504575532072467298394.html. Accessed January 26, 2013.
Fried B, Abruzzi A, 2010. Food-borne trematode infections of humans in the United States of America. Parasitol Res 106: 1263ā1280.
Norton RA, Monroe L, 1961. Infection by Fasciola hepatica acquired in California. Gastroenterology 41: 46ā48.
MacLean JD, Graeme-Cook FM, 2002. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2002. A 50-year-old man with eosinophilia and fluctuating hepatic lesions. N Engl J Med 346: 1232ā1239.
Hauser SC, Bynum TE, 1984. Abnormalities on ERCP in a case of human fascioliasis. Gastrointest Endosc 30: 80ā82.
Hillyer GV, Soler de Galanes M, 1988. Identification of a 17-kilodalton Fasciola hepatica immunodiagnostic antigen by the enzyme-linked immunoelectrotransfer blot technique. J Clin Microbiol 26: 2048ā2053.
Esteban J, Barges M, Mas-Coma S, 1998. Geographical distribution, diagnosis and treatment of human fascioliasis: a review. Res Rev Parisitol 58: 13ā42.
Fürst T, Keiser J, Utzinger J, 2012. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 12: 210ā221.
Mas-Coma S, 2005. Epidemiology of fascioliasis in human endemic areas. J Helminthol 79: 207ā216.
Mas-Coma MS, Esteban JG, Bargues MD, 1999. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 77: 340ā346.
Fürst T, Sayasone S, Odermatt P, Keiser J, Utzinger J, 2012. Manifestation, diagnosis, and management of foodborne trematodiasis. BMJ 344: e4093.
Haag E, 2007. Enemy within. Angus Journal 29: 255ā257. Available at: http://www.angusjournal.com/ArticlePDF/enemywithin.pdf. Accessed April, 4, 2013.
Freeborn S, 1928. Liver Fluke and Stomach Worm of Sheep. California Agricultural Extension Service, Circular 17. The College of Agriculture, University of California. Available at: http://ia600700.us.archive.org/35/items/liverflukestomac17free/liverflukestomac17free.pdf. Accessed April 4, 2013.
Fox NJ, White PC, McClean CJ, Marion G, Evans A, Hutchings MR, 2011. Predicting impacts of climate change on Fasciola hepatica risk. PLoS ONE 6: e16126.
Neff GW, Dinavahi RV, Chase V, Reddy KR, 2001. Laparoscopic appearance of Fasciola hepatica infection. Gastrointest Endosc 53: 668ā671.
Stemmermann GN, 1953. Human infestation with Fasciola gigantica. Am J Pathol 29: 731ā759.
Alatoom A, Sheffield J, Gander RM, Shaw J, Cavuoti D, 2008. Fascioliasis in pregnancy. Obstet Gynecol 112: 483ā485.
Agnamey P, Fortes-Lopes E, Raccurt CP, Boncy J, Totet A, 2012. Cross-sectional serological survey of human fascioliasis in Haiti. J Parasitol Res 2012: 751951.
MartĆnez-Barbabosa I, GutiĆ©rrez-Quiroz M, Romero-Cabello R, Ruiz-GonzĆ”lez L, GutiĆ©rrez-CĆ”rdenas EM, Alpizar-Sosa A, Pimienta-Lastra RdJ, 2006. Seroepidemiology of fascioliasis in school children in Mexico City. Rev Biomed 17: 251ā257. Available at: http://www.medigraphic.com/pdfs/revbio/bio-2006/bio064c.pdf. Accessed April 4, 2013.
Marcos LA, Tagle M, Terashima A, Bussalleu A, Ramirez C, Carrasco C, Valdez L, Huerta-Mercado J, Freedman DO, Vinetz JM, Gotuzzo E, 2008. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis. Am J Trop Med Hyg 78: 222ā227.
Graham CS, Brodie SB, Weller PF, 2001. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. Clin Infect Dis 33: 1ā5.
Favennec L, Jave Ortiz J, Gargala G, Lopez Chegne N, Ayoub A, Rossignol JF, 2003. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment Pharmacol Ther 17: 265ā270.
Apt W, Aguilera X, Vega F, Miranda C, Zulantay I, Perez C, Gabor M, Apt P, 1995. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 52: 532ā535.
Hien TT, Truong NT, Minh NH, Dat HD, Dung NT, Hue NT, Dung TK, Tuan PQ, Campbell JI, Farrar JJ, Day JN, 2008. A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam. Am J Trop Med Hyg 78: 388ā392.
Cuffari C, Oligny L, Seidman EG, 1998. Dientamoeba fragilis masquerading as allergic colitis. J Pediatr Gastroenterol Nutr 26: 16ā20.
Sorvillo F, Ash LR, Berlin OG, Morse SA, 2002. Baylisascaris procyonis: an emerging helminthic zoonosis. Emerg Infect Dis 8: 355ā359.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 17 | 17 | 2 |
Full Text Views | 352 | 171 | 2 |
PDF Downloads | 73 | 29 | 2 |
Two cases of domestically acquired fascioliasis are reported. Patient One was a 63-year-old male who developed a febrile illness 2 months after eating watercress in Marin County. Patient Two was a 38-year-old male who had eaten watercress with Patient One, and also developed a febrile illness. Both patients had eosinophilia and liver lesions on imaging. Diagnosis was made by serology and treatment was with triclabendazole.
Disclosure: Portions of these cases were presented as a Poster at the 2012 ID Week in San Diego, California (Poster 1696, October 20, 2012).
Authors' addresses: Scott A. Weisenberg, Associated Internal Medicine Medical Group, Inc., Oakland, CA, E-mail: scottweisenberg@gmail.com. David E. Perlada, Bay Infectious Diseases, Orinda, CA, E-mail: PerladD@sutterhealth.org.
Keiser J, Utzinger J, 2005. Emerging foodborne trematodiasis. Emerg Infect Dis 11: 1507ā1514.
Marcos LA, Terashima A, Gotuzzo E, 2008. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis 21: 523ā530.
Cabada MM, White AC Jr, 2012. New developments in epidemiology, diagnosis, and treatment of fascioliasis. Curr Opin Infect Dis 25: 518ā522.
Welch RD, Smith PH, Malone JB, Holmes RA, Geaghan JP, 1987. Herd evaluation of Fasciola hepatica infection levels in Louisiana cattle by an enzyme-linked immunosorbent assay. Am J Vet Res 48: 345ā347.
Knapp SE, Dunkel AM, Han K, Zimmerman LA, 1992. Epizootiology of fascioliasis in Montana. Vet Parasitol 42: 241ā246.
Kane YI, 2010. A Walk on the Wild Sideāfor Lunch. Wall Street Journal. New York: Dow Jones and Company, Inc. Available at: http://online.wsj.com/article/SB10001424052748704631504575532072467298394.html. Accessed January 26, 2013.
Fried B, Abruzzi A, 2010. Food-borne trematode infections of humans in the United States of America. Parasitol Res 106: 1263ā1280.
Norton RA, Monroe L, 1961. Infection by Fasciola hepatica acquired in California. Gastroenterology 41: 46ā48.
MacLean JD, Graeme-Cook FM, 2002. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2002. A 50-year-old man with eosinophilia and fluctuating hepatic lesions. N Engl J Med 346: 1232ā1239.
Hauser SC, Bynum TE, 1984. Abnormalities on ERCP in a case of human fascioliasis. Gastrointest Endosc 30: 80ā82.
Hillyer GV, Soler de Galanes M, 1988. Identification of a 17-kilodalton Fasciola hepatica immunodiagnostic antigen by the enzyme-linked immunoelectrotransfer blot technique. J Clin Microbiol 26: 2048ā2053.
Esteban J, Barges M, Mas-Coma S, 1998. Geographical distribution, diagnosis and treatment of human fascioliasis: a review. Res Rev Parisitol 58: 13ā42.
Fürst T, Keiser J, Utzinger J, 2012. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 12: 210ā221.
Mas-Coma S, 2005. Epidemiology of fascioliasis in human endemic areas. J Helminthol 79: 207ā216.
Mas-Coma MS, Esteban JG, Bargues MD, 1999. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 77: 340ā346.
Fürst T, Sayasone S, Odermatt P, Keiser J, Utzinger J, 2012. Manifestation, diagnosis, and management of foodborne trematodiasis. BMJ 344: e4093.
Haag E, 2007. Enemy within. Angus Journal 29: 255ā257. Available at: http://www.angusjournal.com/ArticlePDF/enemywithin.pdf. Accessed April, 4, 2013.
Freeborn S, 1928. Liver Fluke and Stomach Worm of Sheep. California Agricultural Extension Service, Circular 17. The College of Agriculture, University of California. Available at: http://ia600700.us.archive.org/35/items/liverflukestomac17free/liverflukestomac17free.pdf. Accessed April 4, 2013.
Fox NJ, White PC, McClean CJ, Marion G, Evans A, Hutchings MR, 2011. Predicting impacts of climate change on Fasciola hepatica risk. PLoS ONE 6: e16126.
Neff GW, Dinavahi RV, Chase V, Reddy KR, 2001. Laparoscopic appearance of Fasciola hepatica infection. Gastrointest Endosc 53: 668ā671.
Stemmermann GN, 1953. Human infestation with Fasciola gigantica. Am J Pathol 29: 731ā759.
Alatoom A, Sheffield J, Gander RM, Shaw J, Cavuoti D, 2008. Fascioliasis in pregnancy. Obstet Gynecol 112: 483ā485.
Agnamey P, Fortes-Lopes E, Raccurt CP, Boncy J, Totet A, 2012. Cross-sectional serological survey of human fascioliasis in Haiti. J Parasitol Res 2012: 751951.
MartĆnez-Barbabosa I, GutiĆ©rrez-Quiroz M, Romero-Cabello R, Ruiz-GonzĆ”lez L, GutiĆ©rrez-CĆ”rdenas EM, Alpizar-Sosa A, Pimienta-Lastra RdJ, 2006. Seroepidemiology of fascioliasis in school children in Mexico City. Rev Biomed 17: 251ā257. Available at: http://www.medigraphic.com/pdfs/revbio/bio-2006/bio064c.pdf. Accessed April 4, 2013.
Marcos LA, Tagle M, Terashima A, Bussalleu A, Ramirez C, Carrasco C, Valdez L, Huerta-Mercado J, Freedman DO, Vinetz JM, Gotuzzo E, 2008. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis. Am J Trop Med Hyg 78: 222ā227.
Graham CS, Brodie SB, Weller PF, 2001. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. Clin Infect Dis 33: 1ā5.
Favennec L, Jave Ortiz J, Gargala G, Lopez Chegne N, Ayoub A, Rossignol JF, 2003. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment Pharmacol Ther 17: 265ā270.
Apt W, Aguilera X, Vega F, Miranda C, Zulantay I, Perez C, Gabor M, Apt P, 1995. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 52: 532ā535.
Hien TT, Truong NT, Minh NH, Dat HD, Dung NT, Hue NT, Dung TK, Tuan PQ, Campbell JI, Farrar JJ, Day JN, 2008. A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam. Am J Trop Med Hyg 78: 388ā392.
Cuffari C, Oligny L, Seidman EG, 1998. Dientamoeba fragilis masquerading as allergic colitis. J Pediatr Gastroenterol Nutr 26: 16ā20.
Sorvillo F, Ash LR, Berlin OG, Morse SA, 2002. Baylisascaris procyonis: an emerging helminthic zoonosis. Emerg Infect Dis 8: 355ā359.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 17 | 17 | 2 |
Full Text Views | 352 | 171 | 2 |
PDF Downloads | 73 | 29 | 2 |